Sign In
Buy GMAB
$23.88
+0.0300 (+0.126%)
At Close: Jun 03, 2026
Constitution of the Board of Directors in Genmab A/S and Grant of Restricted Stock Units and Warrants to Employees in Genmab
02:21pm, Thursday, 19'th Mar 2026
Company Announcement COPENHAGEN, Denmark; March 19, 2026 – Genmab A/S (Nasdaq: GMAB) Following Genmab A/S' Annual General Meeting held on March 19, 2026, the Company's Board of Directors met to cons
Passing of Genmab A/S' Annual General Meeting
10:06am, Thursday, 19'th Mar 2026
Company Announcement At Genmab A/S' Annual General Meeting held today March 19, 2026, the Annual Report for 2025 was approved Discharge was given to the Board of Directors and the Executive Manage
Completion of Share Buy-back Program
10:09am, Monday, 16'th Mar 2026
Company Announcement COPENHAGEN, Denmark; March 16, 2026 – Genmab A/S (Nasdaq: GMAB) announces that its share buy-back program has been completed on March 13, 2026. On February 17, 2026, Genmab an
Alliancebernstein L.P. Has $335.96 Million Stock Holdings in Genmab A/S Sponsored ADR $GMAB
03:20am, Monday, 16'th Mar 2026
Alliancebernstein L.P. boosted its holdings in shares of Genmab A/S Sponsored ADR (NASDAQ: GMAB) by 2.7% during the third quarter, according to its most recent 13F filing with the Securities and Excha
Genmab A/S (GMAB) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
02:52pm, Wednesday, 11'th Mar 2026
Genmab A/S (GMAB) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Harbor Health Care ETF Q4 2025 Portfolio Review
08:18am, Wednesday, 11'th Mar 2026
Revolution Medicines was a top contributor during the quarter. AbbVie, by contrast, traded largely sideways, as investors continued to assess its post-patent earnings durability. While Eli Lilly deliv
Transactions in Connection with Share Buy-back Program
10:01am, Monday, 09'th Mar 2026
Company Announcement COPENHAGEN, Denmark; March 9, 2026 – Genmab A/S (Nasdaq: GMAB). On February 17, 2026, Genmab announced the initiation of a share buy-back program to repurchase up to 342,130 sha
Correction to Company Announcement No. 13 of March 2, 2026
04:53pm, Monday, 02'nd Mar 2026
Company Announcement COPENHAGEN, Denmark; March 2, 2026 – Genmab A/S (Nasdaq: GMAB) - Correction: In Company Announcement no. 13/2026 regarding transactions with shares and linked securities in G
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
02:58pm, Monday, 02'nd Mar 2026
Company Announcement COPENHAGEN, Denmark; March 2, 2026 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, t
Transactions in Connection with Share Buy-back Program
09:04am, Monday, 02'nd Mar 2026
Company Announcement COPENHAGEN, Denmark; March 2, 2026 – Genmab A/S (Nasdaq: GMAB). On February 17, 2026, Genmab announced the initiation of a share buy-back program to repurchase up to 342,130 sha
Pre-Market Stock Futures: The futures are trading lower after a dreadful Friday and week, one that could be laying the foundation for a larger and more intense sell-off. The combination of the sell-of
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
03:23pm, Friday, 27'th Feb 2026
Company Announcement COPENHAGEN, Denmark; February 27, 2026 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/52
Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab
03:21pm, Friday, 27'th Feb 2026
Company Announcement COPENHAGEN, Denmark; February 27, 2026 – Genmab A/S (Nasdaq: GMAB) announced today that the Board of Directors decided to grant 587,495 restricted stock units to members of mana
Genmab to Participate in Upcoming Investor Conferences
10:27am, Wednesday, 25'th Feb 2026
Media Release COPENHAGEN, Denmark; February 25, 2026 Genmab A/S (Nasdaq: GMAB ) announced today that members of its E xecutive Committee will participat e in fireside chats at the following investor c
Capital Increase in Genmab as a Result of Employee Warrant Exercise
03:20pm, Tuesday, 24'th Feb 2026
Company Announcement COPENHAGEN, Denmark; February 24, 2026 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 12,313 shares as a consequence of the exercise of employee warrants. The in
